Late hair growth may be a potential side effect of taking a combination of antidepressants and cognitive behavioural therapy, new research has suggested.
Key points:Alzheimer’s patients may not benefit from taking the drugsThe drugs are not likely to reduce symptoms of the condition and can lead to cognitive declineTrial results have not been published yetBut research has shown that patients taking the medicines may benefit from the treatments if they are treated within a period of about two years, rather than waiting until they are at least 70.
The drugs were developed by the pharmaceutical company Eli Lilly, which is part of the US company Pfizer.
The trial is the first to look at the effects of taking the medications and found that the drugs did not seem to increase symptoms of Alzheimer’s disease or reduce cognitive decline in those who had lost some hair in the previous year.
The researchers looked at more than 1,000 patients with dementia and Alzheimer’s, and found patients with a loss of hair in both groups were significantly less likely to have cognitive impairment or other side effects than those who did not have hair loss.
The study is the latest in a series of studies that have looked at the potential benefits of antidepressants in the treatment of late hair loss, including a study published in the journal Nature in June.
The results of the study, led by Professor David D. Schubert from the University of Illinois at Chicago, suggest that cognitive benefits of the medication may outweigh any possible risks.
“There are some medications that we know have some benefit to cognitive functioning in the short term and some benefit in the long term, but we do not know the long-term impact of all the drugs that are on the market,” he said.
“This study shows that the drug can be effective at lowering cognitive impairment in patients who have lost hair in one year or more.”
Dr Schuber said the study was based on data from more than 700 patients, who were all treated with the drug at the same time and with different levels of hair loss from those taking the older antidepressants.
“We didn’t have an outcome measure of cognitive function at the beginning of the trial.
We also did not know how the drugs would affect cognitive functioning over time, so we can’t say whether it would have been better to have taken them all at once,” he told the ABC.”
But we were able to find that the medication is associated with a significant reduction in cognitive impairment, and that is very encouraging.”
That’s the kind of result that we hope to see in a larger study, because we don’t want to be relying on a single outcome measure that may not work.
“Professor Schuober said the medication was effective in reducing symptoms of dementia and cognitive decline.”
The treatment that we were looking at had a significant impact on the symptoms of cognitive decline and that was the drug,” he explained.”
It was associated with an improvement in cognitive functioning, but it didn’t necessarily reduce the amount of cognitive impairment.
“The drugs may also improve other aspects of dementia patients’ lives, Professor Schuberg said.
He said that people who were treated with antidepressants at the start of the trials would have a significant benefit.”
One of the things that people often say is that they are not necessarily cured of their disease, they’re just not going to be the same person they were before,” he added.”
If you are a patient who is still on a medication and you are able to reduce the symptoms, you can potentially have a substantial benefit.
“Dr Doreen Jager from the Australian Institute of Health and Welfare said the findings were very encouraging, particularly in terms of the possibility of an extended period of improvement.”
These results suggest that a combination treatment of the drugs might be more effective in patients with mild cognitive impairment than in those with moderate cognitive impairment,” she said.
Professor Jager said it was difficult to know how long a person would be able to take the medications, but the trial results suggest the drugs could be effective for longer than a year.”
Our findings are not really surprising given that there are very large numbers of people who have mild cognitive impairments and moderate cognitive impairions, but mild cognitive deficits are relatively rare, and people with moderate or severe cognitive impairment may not have a need for medication,” she told the Nine Network.”
I think it’s really encouraging that people are still able to get their hair back.